Sign In
28 Nov 2014 07:00
ο»Ώ
Β
Β
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Β
Director's Dealing
Β
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that David Evans, Non-Executive Chairman of the Company, purchased 173,500 ordinary shares in the Company at 15p per share on 27 November 2014.
Β
Following this transaction, Mr Evans' total beneficial holding has increased to 3,043,634 ordinary shares representing 2.8 per cent of the issued ordinary share capital of the Company.
Β
Β
Β
Contacts:Β
Β
Omega Diagnostics Group PLC | Tel: 01259 763 030 or www.omegadiagnostics.com |
Andrew Shepherd, Chief Executive | |
Kieron Harbinson, Group Finance Director JagΒ Grewal,Β GroupΒ SalesΒ andΒ Marketing Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Christopher Raggett (Corporate Finance) Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
Β
Follow the stocks
